Moreover, our results are in agreement with a previous study showing that ADAR1-mediated RNA editing contributes to the prevention of pathogenic immune responses as well as gut inflammation and colitis and inflammatory gastrointestinal problems are sometimes observed in patients with ADAR1 gene mutations (26, 41). This evidence concerns the gene ADAR and colitis.